Table 4.
Number, Rate, and Adjusted Rate Ratio of Primary and Secondary Care Contacts for Patients with Prurigo Nodularis Compared with Those for Controls in the Clinical Practice Research Datalink, 2008–2018
Healthcare Sector | Prurigo Nodularis |
Controls |
Incidence Rate Ratio1 |
||||
---|---|---|---|---|---|---|---|
Contacts | Rate ppy | Contacts | Rate ppy | Rate Ratio | 95% CI | P-Value | |
Main analysis | |||||||
Patients | 2,409 | 2,409 | |||||
All contacts | |||||||
Primary care contacts, n (rate ppy) | 150,140 | 14.77 | 90,981 | 8.94 | 1.48 | 1.47–1.49 | <0.0001 |
Inpatient contacts, n (rate ppy) | 13,235 | 1.30 | 4,677 | 0.46 | 1.80 | 1.75–1.85 | <0.0001 |
Outpatient contacts, n (rate ppy) | 77,683 | 7.64 | 30,956 | 3.04 | 2.15 | 2.13–2.18 | <0.0001 |
Accident and emergency contacts, n (rate ppy) | 6,431 | 0.63 | 3,539 | 0.35 | 1.32 | 1.27–1.36 | <0.0001 |
Prurigo related contacts | |||||||
Primary care contacts, n (rate ppy) | 6,752 | 0.66 | |||||
Inpatient contacts with primary diagnosis, n (rate ppy) | 324 | 0.03 | |||||
Inpatient contacts with any diagnosis, n (rate ppy) | 653 | 0.06 | |||||
Dermatology outpatient contacts, n (rate ppy) | 26,025 | 2.56 | |||||
Sensitivity analysis | |||||||
Patients | |||||||
All contacts | 5,441 | 5,441 | |||||
Primary care contacts, n (rate ppy) | 299,115 | 13.61 | 192,598 | 8.62 | 1.43 | 1.42–1.44 | <0.0001 |
Inpatient contacts, n (rate ppy) | 25,560 | 1.16 | 10,184 | 0.46 | 1.72 | 1.68–1.75 | <0.0001 |
Outpatient contacts, n (rate ppy) | 143,004 | 6.51 | 66,084 | 2.96 | 1.90 | 1.88–1.92 | <0.0001 |
Accident and emergency contacts, n (rate ppy) | 12,679 | 0.58 | 7,600 | 0.34 | 1.28 | 1.25–1.31) | <0.0001 |
Prurigo related contacts | |||||||
Primary care contacts, n (rate ppy) | 8,551 | 0.39 | |||||
Inpatient contacts with primary diagnosis, n (rate ppy) | 429 | 0.02 | |||||
Inpatient contacts with any diagnosis, n (rate ppy) | 761 | 0.03 | |||||
Dermatology outpatient contacts, n (rate ppy) | 37,298 | 1.70 |
Abbreviations: CHD, coronary health disease; CI, confidence interval; CKD, chronic kidney disease; ppy, per patent year; T2DM, type 2 diabetes mellitus.
Adjusted for age at index, gender, baseline CHD, baseline T2DM, baseline CKD, and baseline depression.